Concepedia

Marisa Pardal

MP

5

Publications

124

Citations

5

H-Index

2022

Active since

Affiliations

Universidade do Porto(Current)

AstraZeneca (Portugal)

Centre for Health Technology and Services Research

Hospital Pedro Hispano

Cooperativa de Ensino Superior Politécnico e Universitário

Marisa Pardal is an author at Universidade do Porto specializing in clinical epidemiology, cardiovascular disease, and cardiovascular disease risk assessment.

ORCID

Top concepts

Publications per year

2022–2024

5

Publications

5

Benralizumab in severe eosinophilic asthma by previous biologic use and key clinical subgroups: real-world XALOC-1 programme

David J. Jackson, Girolamo Pelaia, Benjamin Emmanuel et al. · European Respiratory Journal · 2024 · 50 citations · Full text

Cardiovascular Risk Profile and Lipid Management in the Population-Based Cohort Study LATINO: 20 Years of Real-World Data

Cristina Gavina, Daniel Seabra, Marisa Pardal et al. · Journal of Clinical Medicine · 2022 · 23 citations · Full text

, , +28

Prevalence and Characterisation of Patients with Asthma According to Disease Severity in Portugal: Findings from the EPI-ASTHMA Pilot Study

Catarina João, Cristina Jácome, Dinis Brito et al. · Journal of Asthma and Allergy · 2022 · 20 citations · Full text

Twenty years of real-world data to estimate chronic kidney disease prevalence and staging in an unselected population

Carla Santos-Araújo, Luís Mendonça, Daniel Seabra et al. · Clinical Kidney Journal · 2022 · 18 citations · Full text

Portuguese Heart Failure Prevalence Observational Study (PORTHOS) rationale and design – A population-based study

Rui Baptista, José Silva‐Cardoso, Helena Canhão et al. · Revista Portuguesa de Cardiologia · 2023 · 13 citations · Full text

Rows per page

1–5 of 5